Who owns Nektar Therapeutics?

Key details on Nektar Therapeutics (Ticker: NKTR)

Who owns Nektar Therapeutics?

Is NKTR a good stock to own? Find out who bought Nektar Therapeutics, who sold Nektar Therapeutics (NKTR) stock, and who holds a large position in Nektar Therapeutics.

Fund Name Number of Shares Share Valuation As Of
OppenheimerFunds 26.00M $286.00M March 31, 2015
PRIMECAP Management Company 19.55M $215.08M March 31, 2015
HealthCor Management 9.20M $66.88M June 30, 2011
Vanguard 8.74M $96.16M March 31, 2015
First Trust Advisors 6.31M $69.36M March 31, 2015
Ulys 5.17M $28.93M Dec. 31, 2011
BlackRock Fund Advisors 4.87M $53.56M March 31, 2015
STATE STREET CORPORATION 4.81M $52.90M March 31, 2015
JPMORGAN CHASE & CO 4.55M $50.01M March 31, 2015
BlackRock Institutional Trust Company, N.A. 4.37M $48.02M March 31, 2015
Federated Investors 4.25M $46.75M March 31, 2015
Inves 4.13M $64.09M Dec. 31, 2014
HealthCor Management 4.00M $46.20M June 30, 2013
GRANAHAN INVESTMENT MANAGEMENT INC/MA 3.51M $54.40M Dec. 31, 2014
Franklin Resources 3.04M $38.93M June 30, 2014
Deerfield Management Company 2.94M $33.95M June 30, 2013
Artal Group S.A. 2.75M $30.25M March 31, 2013
Invus Public Equities Advisors 2.75M $19.99M June 30, 2011
BVF 2.73M $20.26M Dec. 31, 2012

Who sold Nektar Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbia Wanger Asset Management Dec. 31, 2010 3.49M $44.80M